SCHEMBL28392159

SCHEMBL28392159

Cc1cccc(C(=O)Nc2ccc(-c3cccc4c3C=CCC4)cc2O)c1C

nearest known ligand 0.41

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ RAB9A P51151 4/20 0.41
▸ LMNA P02545 3/20 0.41
▸ HSD17B10 Q99714 3/20 0.41
▸ NPC1 O15118 3/20 0.41
▸ HTT P42858 2/20 0.41
▸ TSHR P16473 2/20 0.41
▸ TP53 P04637 1/20 0.41
▸ ALDH1A1 P00352 4/20 0.36
▸ KDM4E B2RXH2 1/20 0.36
▸ HPGD P15428 1/20 0.36
▸ MAPK1 P28482 1/20 0.36
▸ USP2 O75604 1/20 0.36
▸ KCNMA1 Q12791 1/20 0.35
▸ CRHBP P24387 1/20 0.35
▸ CRHR2 Q13324 1/20 0.35
▸ POLB P06746 1/20 0.34
▸ MAPT P10636 1/20 0.34
▸ MAOB P27338 2/20 0.34
▸ GAA P10253 1/20 0.34
▸ MAOA P21397 1/20 0.34

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28396386 0.89 MAPT (0.40) RAB9ALMNAHSD17B10NPC1HTT
SCHEMBL28420648 0.88 ALDH1A1 (0.45) RAB9ALMNANPC1ALDH1A1KDM4E
SCHEMBL28261354 0.87 TP53 (0.33) RAB9ALMNAHSD17B10NPC1HTT
SCHEMBL28261357 0.78 KDR (0.34) LMNATP53ALDH1A1HPGDMAPK1
SCHEMBL28867050 0.77 CD274 (0.37) LMNAALDH1A1KDM4EMAPTGAA
SCHEMBL28419971 0.75 MAPT (0.44) RAB9ANPC1HTTTP53ALDH1A1
SCHEMBL28261326 0.75 MAPT (0.32) ALDH1A1MAPTGAA
SCHEMBL28426457 0.72 CHRNB2 (0.43) LMNATSHRALDH1A1POLBGAA
SCHEMBL28259961 0.71 MEN1 (0.47) LMNAHTTTSHRTP53ALDH1A1
SCHEMBL27972279 0.71 FADS1 (0.39) RAB9ALMNAHSD17B10NPC1HTT

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-104066724-B P2X4 receptor antagonists 日本化学药品株式会社 2020-04-17 — — CN disclosed
Send feedback